Liver-selective distribution in rats supports the importance of active uptake into the liver via organic anion transporting polypeptides (OATPs) in humans

Kalliokoski, 2009, Impact of OATP transporters on pharmacokinetics, Br J Pharmacol, 158, 693, 10.1111/j.1476-5381.2009.00430.x Watanabe, 2010, Investigation of the rate-determining process in the hepatic elimination of HMG-CoA reductase inhibitors in rats and humans, Drug Metab Dispos, 38, 215, 10.1124/dmd.109.030254 Nakai, 2001, Human liver-specific organic anion transporter, LST-1, mediates uptake of pravastatin by human hepatocytes, J Pharmacol Exp Ther, 297, 861 Komai, 1992, Disposition and metabolism of pravastatin sodium in rats, dogs and monkeys, Eur J Drug Metab Pharmacokinet, 17, 103, 10.1007/BF03188778 Regazzi, 1993, Altered disposition of pravastatin following concomitant drug therapy with cyclosporin A in transplant recipients, Transpl Proc, 25, 2732 Niemi, 2004, High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1), Pharmacogenetics, 14, 429, 10.1097/01.fpc.0000114750.08559.32 Mwinyi, 2004, Evidence for inverse effects of OATP-C (SLC21A6) 5 and 1b haplotypes on pravastatin kinetics, Clin Pharmacol Ther, 75, 415, 10.1016/j.clpt.2003.12.016 Tornio, 2012, Drug interactions with oral antidiabetic agents: pharmacokinetic mechanisms and clinical implications, Trends Pharmacol Sci, 33, 312, 10.1016/j.tips.2012.03.001 Niemi, 2003, Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics and pharmacodynamics of repaglinide: potentially hazardous interaction between gemfibrozil and repaglinide, Diabetologia, 46, 347, 10.1007/s00125-003-1034-7 Niemi, 2005, Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics, Clin Pharmacol Ther, 77, 468, 10.1016/j.clpt.2005.01.018 Nezasa, 2002, Pharmacokinetics and disposition of rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in rat, Xenobiotica, 32, 715, 10.1080/00498250210144820 Imaoka, 2013, Integrated approach of in vivo and in vitro evaluation of the involvement of hepatic uptake organic anion transporters in the drug disposition in rats using rifampicin as an inhibitor, Drug Metab Dispos, 41, 1442, 10.1124/dmd.113.051052 Muck, 1999, Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporine-treated kidney transplant recipients, Clin Pharmacol Ther, 65, 251, 10.1016/S0009-9236(99)70104-9 Marciante, 2011, Cerivastatin, genetic variants, and the risk of rhabdomyolysis, Pharmacogenet Genomics, 21, 280, 10.1097/FPC.0b013e328343dd7d Repaglinide new drug application [NDA]. Available at the website of PMDA: http://www.info.pmda.go.jp/shinyaku/P201100017/index.html. Ezetimibe new drug application [NDA]. Available at the website of PMDA: http://www.info.pmda.go.jp/shinyaku/P200700023/index.html. Olmesartan drug approval package. Available at the website of FDA: http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-286_Benicar_pharmr_P2.pdf. Uchiyama, 1990, Metabolic fate of simvastatin, an inhibitor of HMG-CoA reductase(1): absorption, distribution, metabolism and excretion of [14C] simvastatin after single administration in male rats, Yakubutsudoutai, 5, 133 Rodgers, 2005, Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases, J Pharm Sci, 94, 1259, 10.1002/jps.20322 Rodgers, 2006, Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions, J Pharm Sci, 95, 1238, 10.1002/jps.20502 Smith, 2015, Volume of distribution in drug design, J Med Chem, 10.1021/acs.jmedchem.5b00201 Murakami, 2011, Role of phosphatidylserine binding in tissue distribution of amine-containing basic compounds, Expert Opin Drug Metab Toxicol, 7, 353, 10.1517/17425255.2011.548805 Chu, 2013, Species differences in drug transporters and implications for translating preclinical findings to humans, Expert Opin Drug Metab Toxicol, 9, 237, 10.1517/17425255.2013.741589 Hagenbuch, 2003, The superfamily of organic anion transporting polypeptides, Biochim Biophys Acta, 1609, 1, 10.1016/S0005-2736(02)00633-8